financetom
Business
financetom
/
Business
/
Meta Platforms Insider Sold Shares Worth $8,599,720, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta Platforms Insider Sold Shares Worth $8,599,720, According to a Recent SEC Filing
Aug 15, 2024 12:36 AM

03:09 AM EDT, 08/15/2024 (MT Newswires) -- Mark Zuckerberg, 10% Owner, Director, Chair of Board and Chief Executive Officer, on August 12, 2024, sold 16,702 shares in Meta Platforms ( META ) for $8,599,720. Following the Form 4 filing with the SEC, Zuckerberg has control over a total of 89,927 shares of the company, with 89,927 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1326801/000095010324012229/xslF345X03/dp216661_4-zuckerberg0812.xml

Price: 526.00, Change: -0.76, Percent Change: -0.14

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Nvidia Short Sellers Amass $6.6 Billion in Profits Amid Frenzy Over DeepSeek
Market Chatter: Nvidia Short Sellers Amass $6.6 Billion in Profits Amid Frenzy Over DeepSeek
Jan 28, 2025
03:06 PM EST, 01/28/2025 (MT Newswires) -- Bets against Nvidia ( NVDA ) amid a surge in interest for Chinese artificial intelligence app DeepSeek yielded one-day gains of about $6.6 billion for short sellers, Reuters reported Tuesday, citing data analytics firm Ortex. Short positions in Broadcom ( AVGO ) resulted in more than $2 billion in profits, the report added....
--MGIC Investment Keeps Quarterly Dividend at $0.13 a Share, Payable March 5 to Holders on Feb. 18
--MGIC Investment Keeps Quarterly Dividend at $0.13 a Share, Payable March 5 to Holders on Feb. 18
Jan 28, 2025
03:13 PM EST, 01/28/2025 (MT Newswires) -- Price: 25.49, Change: -0.09, Percent Change: -0.37 ...
US FDA approves Novo Nordisk's Ozempic to reduce diabetic kidney disease progression
US FDA approves Novo Nordisk's Ozempic to reduce diabetic kidney disease progression
Jan 28, 2025
Jan 28 (Reuters) - Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of chronic kidney disease and the organ's failure, and death due to heart problems in adults with type 2 diabetes. Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same...
Tower Semiconductor Analyst Sees 'Attractive' Buying Opportunity Following DeepSeek Selloff
Tower Semiconductor Analyst Sees 'Attractive' Buying Opportunity Following DeepSeek Selloff
Jan 28, 2025
Benchmark analyst Cody Acree named Tower Semiconductor ( TSEM ) Inc. among recommended oversold names following Monday’s market rout, which was triggered by DeepSeek’s announcement of its advanced language model. Monday’s Selloff: Chinese AI lab DeepSeek unveiled a new large language model reportedly meeting or exceeding leading competitors’ performance at a fraction of the cost. The claims, though met with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved